A

Adamas Pharmaceuticals, Inc.

58 employees

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Multiple Sclerosis
Biotechnology
Health Care
Alzheimer's Disease
Therapeutics
Pharmaceutical
Parkinson's Disease

Date founded

2002

Funding rounds raised

Total raised

$40M

from 5 investors over 5 rounds

A

Adamas Pharmaceuticals, Inc. raised $40M on October 1, 2009

Investors: Aeris Capital AG, Mohr Davidow Ventures, DAG Ventures and Northgate Capital

A

Adamas Pharmaceuticals, Inc. raised $21M on May 1, 2005

Investors: Mohr Davidow Ventures

FAQ